BamSEC and AlphaSense Join Forces
Learn More

Alaunos Therapeutics Inc.

NASDAQ: TCRT    
Share price (12/24/24): $1.96    
Market cap (12/24/24): $3.138 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q Pdf Courtesy Copy
12/34/56
EX-10.1
from 10-Q 2 pages Material contract
12/34/56
EX-10.62
from 10-K 9 pages Consulting Agreement
12/34/56
EX-10.61
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.60
from 10-K 10 pages Termination of Employment. Effective December 22, 2023, You Will Be Relieved of All Duties and Not Required to Perform Any Additional Services, You Will Be Paid Through and Including December 22, 2023, Which Shall Be Your Last Day of Employment With the Company (The “Separation Date”). the Company Will Pay You All Wages Earned and Any Accrued and Unused Pto in Accordance With the Company’s Policies Through Your Separation Date. You Will Receive These Amounts Regardless of Whether You Sign This Agreement. 2. Separation Pay
12/34/56
EX-10.59
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Confidential
12/34/56
EX-10.1
from 10-Q 9 pages Confidential
12/34/56
EX-10
from 10-Q 15 pages Employment Agreement
12/34/56
EX-10
from 10-Q 4 pages Severance Agreement
12/34/56
EX-10
from 10-Q 3 pages October 29, 2018 Drew Deniger Dear Drew,
12/34/56
EX-10
from 10-Q 33 pages Article 1 Definitions
12/34/56
EX-10.2
from 10-Q 43 pages Alaunos Therapeutics, Inc. Equity Distribution Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Material contract
12/34/56
EX-10.53
from 10-K 14 pages March 28, 2022 by Email
12/34/56
EX-10.44
from 10-K 5 pages Amendment #3 Cooperative Research and Development Agreement # 03111 Signatures on the Following Page
12/34/56
EX-10.40
from 10-K 7 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because Alaunos Therapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Is Customarily and Actually Treated as Private. Public Health Service Amendment
12/34/56
EX-10.39
from 10-K 7 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because Alaunos Therapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Is Customarily and Actually Treated as Private. Public Health Service Amendment
12/34/56
EX-10.38
from 10-K 8 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because Alaunos Therapeutics, Inc. Has Determined the Information (I) Is Not Material and (II) Is Customarily and Actually Treated as Private. Public Health Service Amendment
12/34/56
EX-10.22
from 10-K 4 pages Amendment to Employment Agreement
12/34/56